Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference to be held on April 27-28, 2022. Individual investors, institutional investors, advisors, and analysts are invited to attend this two-day virtual event showcasing live company presentations and interactive discussions focused on psychedelic treatments for mental health disorders.

“As we have seen over the past 18 months, drug development is hard. The good news is many of the companies presenting over the two-day event have shown tremendous clinical progress. I would encourage investors to take a traditional pharma or biotech view of this space and practice patience, do the proper diligence, and the rewards will be tremendous,” said Lewis Goldberg, Managing Partner and Founder of KCSA’s Psychedelics Practice. “Drug development for mental health care takes time, focus, and is capital intensive. The potential returns remain as dramatic as ever, it’s the investors who – to steal a line from Michael Pollan – need to change their minds.”

REGISTER NOW AT: https://bit.ly/3rFbSuZ

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations and schedule 1x1 meetings.

April 27^th Agenda:

April 28^th Agenda:

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences^®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.